Replay available

USANA Health Sciences, Inc. (USNA) Q1 2026 Earnings Call

USANA Health Sciences, Inc. (NYSE: USNA) Q1 2026 earnings conference call, held 2026-05-06. Replay captured from the company's public earnings webcast.

Wed, May 6, 2026 at 11:00 AMendedReplay
USANA Health Sciences, Inc. (USNA) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Andrew Masuda

Host, Investor Relations

Kevin Guest

Chairman and Chief Executive Officer

Brent Neidig

Chief Commercial Officer

Dr. Catherine Armstrong

Chief Science Officer

Walter Note

Chief Operating Officer

Doug Hecking

Chief Financial Officer

Anthony Libidzinski

Analyst, Sidodian Company

Ivan Feintsev

Analyst, Tigris Financial Partners

Replay transcript excerpt

Greetings and welcome to the USANA Health Sciences first quarter 2026 earnings call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to your host, Andrew Masuda. Please go ahead, sir. Thank you, Carrie, and good morning, everyone. We appreciate you joining us to review our first quarter results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.isana.com. Shortly following the call, a replay will be available on our website. As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ, perhaps materially, from the results projected in such forward-looking statements. Examples of these statements include those regarding our strategies and outlook for fiscal year 2026, uncertainty related to the economic and operating environment around the world, and our operations and financial results. We caution you that these statements should be considered in conjunction with disclosures, including specific risk factors and financial data contained in our most recent filings with the SEC. I'm joined by our Chairman and Chief Executive Officer, Kevin Guest, our Chief Financial Officer, Doug Hecking, our Chief Commercial Officer, Brent Neidig, our Chief Operating Officer, Walter Note, as well as other executives. Yesterday, after the market ...

More from Usana Health Sciences, Inc.